{"id":"activematrix","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the activity of matrix metalloproteinases, enzymes involved in the breakdown of the extracellular matrix. This mechanism is thought to contribute to its therapeutic effects in various conditions.","oneSentence":"ActiveMatrix is a matrix metalloproteinase inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:17:42.579Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of glioblastoma"}]},"trialDetails":[{"nctId":"NCT05844930","phase":"PHASE4","title":"A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-01-03","conditions":"Adhesive Capsulitis","enrollment":56},{"nctId":"NCT05894265","phase":"NA","title":"Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-06-14","conditions":"Rotator Cuff Tears","enrollment":60},{"nctId":"NCT05297513","phase":"PHASE4","title":"Efficacy of ActiveMatrix on Spinal SSI Rate","status":"NOT_YET_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2022-07","conditions":"Spinal Stenosis Lumbar, Surgical Site Infection, Back Pain Lower Back Chronic","enrollment":275}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":230,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"ActiveMatrix","genericName":"ActiveMatrix","companyName":"Baylor College of Medicine","companyId":"baylor-college-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ActiveMatrix is a matrix metalloproteinase inhibitor. Used for Treatment of glioblastoma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}